These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 750115)

  • 1. Immunoglobulins in myasthenia gravis. Kinetic properties of the acetylcholine-receptor antibody studied during lymph drainage.
    Lefvert AK
    Clin Exp Immunol; 1978 Oct; 34(1):111-7. PubMed ID: 750115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
    Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholine receptor antibody synthesis in lymphocyte cultures.
    McLachlan SM; Nicholson LV; Venables G; Mastalgia FL; Bates D; Smith BR; Hall R
    J Clin Lab Immunol; 1981 May; 5(3):137-42. PubMed ID: 7241564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
    Pták J
    Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):257-65. PubMed ID: 6813004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptor.
    Lisak RP; Laramore C; Levinson AI; Zweiman B; Moskovitz AR
    Ann Neurol; 1986 Jan; 19(1):87-9. PubMed ID: 2936299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrathecal immunoactivation in the patients with myasthenia gravis--autoantibodies in the cerebrospinal fluid].
    Yamanaka N; Araki S
    Rinsho Shinkeigaku; 1989 Jan; 29(1):13-7. PubMed ID: 2743683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmapheresis in the treatment of myasthenia gravis.
    Lenzhofer R; Graninger W; Dittrich C; Mamoli B; Zeitlhofer J; Pateisky K
    Wien Klin Wochenschr; 1983 Apr; 95(8):266-71. PubMed ID: 6603717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term follow-up study of anti-acetylcholine receptor antibody titers and clinical symptoms in patients with myasthenia gravis].
    Komiya T; Sato T
    Rinsho Shinkeigaku; 1988 Jul; 28(7):727-34. PubMed ID: 3233845
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3.
    Rødgaard A; Nielsen FC; Djurup R; Somnier F; Gammeltoft S
    Clin Exp Immunol; 1987 Jan; 67(1):82-8. PubMed ID: 3621677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of myasthenia gravis.
    Fulpius BW
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):25-31. PubMed ID: 667413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acetylcholine receptor antibodies in myasthenia gravis].
    Yakirevich V; Snir E; Brener T; Borenstein N; Vidne BA
    Harefuah; 1983 Apr; 104(7):269-70. PubMed ID: 6618324
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis.
    Kagotani K; Monden Y; Nakahara K; Fujii Y; Seike Y; Kitamura S; Masaoka A; Kawashima Y
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):7-12. PubMed ID: 4010323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.
    Lefvert AK; Bergström K; Matell G; Osterman PO; Pirskanen R
    J Neurol Neurosurg Psychiatry; 1978 May; 41(5):394-403. PubMed ID: 207825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.